{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:04:07Z","timestamp":1791313447400,"version":"4.3.1"},"reference-count":112,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Italian Minister of University PON Micromap","award":["01-02589"],"award-info":[{"award-number":["01-02589"]}]}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ijantimicag.2015.05.008","type":"journal-article","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T04:25:12Z","timestamp":1434687912000},"page":"278-289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["Insights and clinical perspectives of daptomycin resistance in Staphylococcus aureus: A review of the available evidence"],"prefix":"10.1016","volume":"46","author":[{"given":"Stefania","family":"Stefani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floriana","family":"Campanile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Santagati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lina","family":"Mezzatesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Cafiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Pacini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.ijantimicag.2015.05.008_bib0565","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1086\/320184","volume":"32","author":"Diekema","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0570","series-title":"16th International Symposium on Staphylococci and Staphylococcal Infections (ISSSI14)","article-title":"Snapshot of MRSA epidemiology and molecular behavior in Italy","author":"Campanile","year":"2014"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0575","series-title":"Antimicrobial resistance interactive database (EARS-Net)","author":"European Centre for Disease Prevention and Control","year":"2015"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0580","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1086\/591861","article-title":"NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006\u20132007","volume":"29","author":"Hidron","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0585","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.coph.2010.06.006","article-title":"Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus","volume":"10","author":"Nannini","year":"2010","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0590","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jgar.2014.02.003","article-title":"Meticillin-resistant Staphylococcus aureus (MRSA) update: new insights into bacterial adaptation and therapeutic targets","volume":"2","author":"Purrello","year":"2014","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0595","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1086\/520655","article-title":"Perspectives on daptomycin resistance, with emphasis on resistance in Staphylococcus aureus","volume":"45","author":"Boucher","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2015.05.008_bib0600","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1093\/cid\/cit613","article-title":"Methicillin-resistant Staphylococcus aureus: an evolving pathogen","volume":"58","author":"Stryjewski","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0605","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrmicro2200","article-title":"Waves of resistance: Staphylococcus aureus in the antibiotic era","volume":"7","author":"Chambers","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0610","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/bmj.1.5219.124-a","article-title":"\u2018Celbenin\u2019-resistant staphylococci","volume":"1","author":"Jevons","year":"1961","journal-title":"Br Med J"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0615","doi-asserted-by":"crossref","first-page":"40802","DOI":"10.1074\/jbc.M403589200","article-title":"The basis for resistance to \u03b2-lactam antibiotics by penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus","volume":"279","author":"Fuda","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0620","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1476-0711-8-22","article-title":"Hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) in Italy","volume":"8","author":"Campanile","year":"2009","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0625","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0140-6736(01)05410-1","article-title":"Linezolid resistance in a clinical isolate of Staphylococcus aureus","volume":"358","author":"Tsiodras","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0630","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1086\/432121","article-title":"Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection","volume":"41","author":"Munoz-Price","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0635","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijantimicag.2013.10.001","article-title":"dltA overexpression: a strain-independent keystone of daptomycin resistance in methicillin-resistant Staphylococcus aureus","volume":"43","author":"Cafiso","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0640","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1128\/JCM.02187-13","article-title":"Report of the 13th vancomycin-resistant Staphylococcus aureus isolate from the United States","volume":"52","author":"Limbago","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0645","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00112-12","article-title":"Comparative genomics of vancomycin-resistant Staphylococcus aureus strains and their positions within the clade most commonly associated with methicillin-resistant S. aureus hospital-acquired infection in the United States","volume":"3","author":"Kos","year":"2012","journal-title":"mBio"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0650","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1099\/jmm.0.47144-0","article-title":"Identification and characterization of a vancomycin-resistant Staphylococcus aureus isolated from Kolkata (South Asia)","volume":"57","author":"Saha","year":"2008","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0655","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1128\/JCM.01727-12","article-title":"Genetic characterization of a vancomycin-resistant Staphylococcus aureus isolate from the respiratory tract of a patient in a university hospital in northeastern Iran","volume":"50","author":"Azimian","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0660","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJMoa1303359","article-title":"Transferable vancomycin resistance in a community-associated MRSA lineage","volume":"370","author":"Rossi","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0665","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ijantimicag.2012.06.005","article-title":"Comparison of antimicrobial pharmacokinetic\/pharmacodynamic breakpoints with EUCAST and CLSI clinical breakpoints for Gram-positive bacteria","volume":"40","author":"As\u00edn","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0670","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/jac\/dkm536","article-title":"Antimicrobial breakpoints for Gram-negative aerobic bacteria based on pharmacokinetic\u2013pharmacodynamic models with Monte Carlo simulation","volume":"61","author":"Frei","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0675","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/jac\/dkq449","article-title":"Monte Carlo simulations: maximizing antibiotic pharmacokinetic data to optimize clinical practice for critically ill patients","volume":"66","author":"Roberts","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0680","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/lt.20885","article-title":"Successful salvage therapy with tigecycline after linezolid failure in a liver transplant recipient with MRSA pneumonia","volume":"12","author":"Saner","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0685","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/jac\/dkn519","article-title":"Failure of linezolid therapy for post-neurosurgical meningitis due to Enterococcus faecium","volume":"63","author":"Webster","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0690","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1128\/AAC.00113-08","article-title":"Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin","volume":"52","author":"Lodise","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0695","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fpubh.2014.00217","article-title":"Vancomycin revisited\u201460 years later","volume":"2","author":"Rubinstein","year":"2014","journal-title":"Front Public Health"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0700","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jmii.2011.11.006","article-title":"Impact of vancomycin MIC creep on patients with methicillin-resistant Staphylococcus aureus bacteremia","volume":"45","author":"Yeh","year":"2012","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0705","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.diagmicrobio.2014.09.016","article-title":"A 5-year survey of antimicrobial susceptibility profiles of methicillin-resistant Staphylococcus aureus (MRSA) isolated from patients with bloodstream infections in Northeast Italy","volume":"81","author":"Cojutti","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0710","series-title":"EUCAST guidelines for the detection of resistance mechanisms and specific resistances of clinical and\/or epidemiological importance","author":"European Committee on Antimicrobial Susceptibility Testing","year":"2013"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0715","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/CMR.00042-09","article-title":"Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications","volume":"23","author":"Howden","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0720","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1128\/AAC.01133-10","article-title":"Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates","volume":"55","author":"van Hal","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0725","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1128\/AAC.04765-14","article-title":"Clinical and microbiologic analysis of the risk factors for mortality in patients with heterogeneous vancomycin-intermediate Staphylococcus aureus bacteremia","volume":"59","author":"Chong","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0730","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/1469-0691.12705","article-title":"New epidemiology of Staphylococcus aureus infection in Asia","volume":"20","author":"Chen","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0735","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1001\/jama.2014.6364","article-title":"Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis","volume":"312","author":"Kalil","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0740","doi-asserted-by":"crossref","first-page":"e29573","DOI":"10.1371\/journal.pone.0029573","article-title":"Modulating activity of vancomycin and daptomycin on the expression of autolysis cell-wall turnover and membrane charge genes in hVISA and VISA strains","volume":"7","author":"Cafiso","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0745","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1473-3099(01)00091-3","article-title":"Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance","volume":"1","author":"Hiramatsu","year":"2001","journal-title":"Lancet Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2015.05.008_bib0750","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1086\/647938","article-title":"Daptomycin: from the mountain to the clinic, with essential help from Francis Tally, MD","volume":"50","author":"Eisenstein","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0755","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.bbamem.2011.01.001","article-title":"Oligomerization of daptomycin on membranes","volume":"1808","author":"Muraih","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0760","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1128\/AAC.35.11.2282","article-title":"Daptomycin disrupts membrane potential in growing Staphylococcus aureus","volume":"35","author":"Alborn","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0765","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1128\/AAC.47.8.2538-2544.2003","article-title":"Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus","volume":"47","author":"Silverman","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0770","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.bbamem.2014.05.014","article-title":"Daptomycin forms cation- and size-selective pores in model membranes","volume":"1838","author":"Zhang","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0775","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1128\/AAC.01410-07","article-title":"Daptomycin exerts bactericidal activity without lysis of Staphylococcus aureus","volume":"52","author":"Cotroneo","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0780","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1128\/JB.00011-12","article-title":"Daptomycin-mediated reorganization of membrane architecture causes mislocalization of essential cell division proteins","volume":"194","author":"Pogliano","year":"2012","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0785","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1086\/507109","article-title":"The activity of daptomycin against wild-type Staphylococcus aureus and strains with reduced susceptibility to vancomycin","volume":"43","author":"Sader","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0790","doi-asserted-by":"crossref","first-page":"e67398","DOI":"10.1371\/journal.pone.0067398","article-title":"Increased cell wall teichoic acid production and d-alanylation are common phenotypes among daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates","volume":"8","author":"Bertsche","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0795","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1128\/AAC.02182-12","article-title":"Correlation of cell membrane lipid profiles with daptomycin resistance in methicillin-resistant Staphylococcus aureus","volume":"57","author":"Mishra","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0800","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1128\/AAC.00223-11","article-title":"In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates","volume":"55","author":"Mishra","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0805","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1086\/648473","article-title":"Enhanced expression of dltABCD is associated with the development of daptomycin nonsusceptibility in a clinical endocarditis isolate of Staphylococcus aureus","volume":"200","author":"Yang","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0810","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1056\/NEJMoa1011138","article-title":"Genetic basis for in vivo daptomycin resistance in enterococci","volume":"365","author":"Arias","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0815","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/AAC.00719-07","article-title":"Failures in clinical treatment of Staphylococcus aureus infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding","volume":"52","author":"Jones","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0820","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1093\/jac\/dkt117","article-title":"Evolution of high-level daptomycin resistance in Enterococcus faecium during daptomycin therapy is associated with limited mutations in the bacterial genome","volume":"68","author":"Kelesidis","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0825","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00281-13","article-title":"Daptomycin-resistant Enterococcus faecalis diverts the antibiotic molecule from the division septum and remodels cell membrane phospholipids","volume":"4","author":"Tran","year":"2013","journal-title":"MBio"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0830","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1128\/AAC.00122-10","article-title":"Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus: evidence for multiple resistance mechanisms","volume":"54","author":"Yang","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0835","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1749-6632.2012.06819.x","article-title":"Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall","volume":"1277","author":"Bayer","year":"2013","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0840","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1128\/CMR.00030-13","article-title":"A current perspective on daptomycin for the clinical microbiologist","volume":"26","author":"Humphries","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0845","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ijantimicag.2006.05.030","article-title":"Mechanisms of daptomycin resistance in Staphylococcus aureus","volume":"28","author":"Kaatz","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0850","doi-asserted-by":"crossref","first-page":"e107426","DOI":"10.1371\/journal.pone.0107426","article-title":"Phenotypic and genotypic characterization of daptomycin-resistant methicillin-resistant Staphylococcus aureus strains: relative roles of mprF and dlt operons","volume":"9","author":"Mishra","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0855","doi-asserted-by":"crossref","first-page":"e1000660","DOI":"10.1371\/journal.ppat.1000660","article-title":"The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion","volume":"5","author":"Ernst","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0860","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1128\/AAC.03422-14","article-title":"Heterogeneity of mprF sequences in methicillin-resistant Staphylococcus aureus clinical isolates: role in cross-resistance between daptomycin and host defense antimicrobial peptides","volume":"58","author":"Bayer","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0865","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ijantimicag.2014.01.018","article-title":"Daptomycin activity tested against 164457 bacterial isolates from hospitalised patients: summary of 8 years of a Worldwide Surveillance Programme (2005\u20132012)","volume":"43","author":"Sader","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0870","series-title":"44th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)","article-title":"Emergence of daptomycin resistance and treatment failure in 2 cases of S. aureus osteomyelitis","author":"Rezai","year":"2004"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0875","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1086\/428616","article-title":"Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia","volume":"40","author":"Mangili","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0880","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1128\/JCM.43.10.5285-5287.2005","article-title":"Development of daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus","volume":"43","author":"Hayden","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0885","doi-asserted-by":"crossref","first-page":"5384","DOI":"10.1128\/JCM.43.10.5384-5387.2005","article-title":"Clinical progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis associated with reduced susceptibility to daptomycin","volume":"43","author":"Vikram","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0890","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1086\/502688","article-title":"Diminished susceptibility to daptomycin accompanied by clinical failure in a patient with methicillin-resistant Staphylococcus aureus bacteremia","volume":"27","author":"Hirschwerk","year":"2006","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0895","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1128\/JCM.44.2.595-597.2006","article-title":"Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis","volume":"44","author":"Marty","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0900","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1128\/JCM.44.2.655-656.2006","article-title":"Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin","volume":"44","author":"Skiest","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0905","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1186\/1471-2334-14-459","article-title":"First case report of vancomycin-intermediate sequence type 72 Staphylococcus aureus with nonsusceptibility to daptomycin","volume":"14","author":"Tsukimori","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0910","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/jac\/dkl256","article-title":"Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapy","volume":"58","author":"Mariani","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0915","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1128\/AAC.00559-07","article-title":"Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis","volume":"51","author":"Julian","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0920","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1128\/JCM.01844-07","article-title":"Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan","volume":"46","author":"Huang","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0925","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1099\/jmm.0.2008\/000588-0","article-title":"Daptomycin non-susceptible meticillin-resistant Staphylococcus aureus USA 300 isolate","volume":"57","author":"Murthy","year":"2008","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0930","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.diagmicrobio.2007.11.002","article-title":"Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus","volume":"60","author":"Bennett","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0935","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1128\/JCM.00660-07","article-title":"Evaluation of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin","volume":"46","author":"Sakoulas","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0940","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1086\/591280","article-title":"Fatal bacteremic mycotic aneurysm complicated by acute renal failure caused by daptomycin-nonsusceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus","volume":"47","author":"Kuo","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0945","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10096-007-0455-5","article-title":"High rate of decreasing daptomycin susceptibility during the treatment of persistent Staphylococcus aureus bacteremia","volume":"27","author":"Sharma","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0950","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ijantimicag.2008.12.010","article-title":"Characterisation of a Staphylococcus aureus strain with progressive loss of susceptibility to vancomycin and daptomycin during therapy","volume":"33","author":"Tenover","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0955","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s10096-008-0692-2","article-title":"Daptomycin resistance and treatment failure following vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE)","volume":"28","author":"Cunha","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0960","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijantimicag.2008.06.028","article-title":"Fatal bacteraemia caused by daptomycin-non-susceptible, vancomycin-intermediate, meticillin-resistant Staphylococcus aureus in a patient with chronic kidney disease","volume":"33","author":"Kuo","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0965","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1099\/jmm.0.006486-0","article-title":"In vivo development of heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA), GISA and daptomycin resistance in a patient with meticillin-resistant S. aureus endocarditis","volume":"58","author":"Kirby","year":"2009","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0970","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1099\/jmm.0.022533-0","article-title":"Six cases of daptomycin-non-susceptible Staphylococcus aureus bacteraemia in Singapore","volume":"59","author":"Hsu","year":"2010","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0975","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1128\/AAC.00533-10","article-title":"Development of daptomycin nonsusceptibility with heterogeneous vancomycin-intermediate resistance and oxacillin susceptibility in methicillin-resistant Staphylococcus aureus during high-dose daptomycin treatment","volume":"54","author":"Lee","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0980","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3109\/00365548.2010.524662","article-title":"Daptomycin non-susceptible, vancomycin intermediate methicillin-resistant Staphylococcus aureus ST398 from a chronic leg ulcer, Italy","volume":"42","author":"Mammina","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0985","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1128\/AAC.01593-10","article-title":"Comparative genome sequencing of an isogenic pair of USA800 clinical methicillin-resistant Staphylococcus aureus isolates obtained before and after daptomycin treatment failure","volume":"55","author":"Boyle-Vavra","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0990","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/jac\/dkr066","article-title":"Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure","volume":"66","author":"Kelley","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib0995","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10096-010-1128-3","article-title":"Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naive patient\u2014a review of the literature","volume":"30","author":"van Hal","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib1000","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-2334-11-152","article-title":"High-dose daptomycin and fosfomycin treatment of a patient with endocarditis caused by daptomycin-nonsusceptible Staphylococcus aureus: case report","volume":"11","author":"Chen","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib1005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s15010-011-0103-y","article-title":"Glycopeptide and daptomycin resistance in community-associated MRSA in the UK","volume":"39","author":"Kirby","year":"2011","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib1010","doi-asserted-by":"crossref","first-page":"e603","DOI":"10.3928\/01477447-20120327-42","article-title":"Daptomycin resistance in prosthetic joint infections","volume":"35","author":"Sivakumar","year":"2012","journal-title":"Orthopedics"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib1015","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1155\/2012\/138470","article-title":"Daptomycin-nonsusceptible, vancomycin-intermediate, methicillin-resistant Staphylococcus aureus endocarditis","volume":"23","author":"Yu","year":"2012","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib1020","doi-asserted-by":"crossref","first-page":"E89","DOI":"10.1111\/j.1399-3062.2012.00775.x","article-title":"Successful treatment of a left ventricular assist device infection with daptomycin non-susceptible methicillin-resistant Staphylococcus aureus: case report and review of the literature","volume":"14","author":"Levy","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib1025","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1093\/jac\/dkt009","article-title":"Ceftaroline in the treatment of concomitant methicillin-resistant and daptomycin-non-susceptible Staphylococcus aureus infective endocarditis and osteomyelitis: case report","volume":"68","author":"Jongsma","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib1030","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/1469-0691.12171","article-title":"Daptomycin non-susceptible Staphylococcus aureus at a US medical centre","volume":"19","author":"Velazquez","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib1035","doi-asserted-by":"crossref","first-page":"e1076","DOI":"10.1016\/j.ijid.2013.02.019","article-title":"In vivo acquired daptomycin resistance during treatment of methicillin-resistant Staphylococcus aureus endocarditis","volume":"17","author":"Dortet","year":"2013","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib1040","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/jac\/dkt396","article-title":"Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin","volume":"69","author":"Gasch","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib1045","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cid\/cir034","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib1050","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10156-012-0501-9","article-title":"Efficacy and safety of intravenous daptomycin in Japanese patients with skin and soft tissue infections","volume":"19","author":"Aikawa","year":"2013","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib1055","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s10156-013-0559-z","article-title":"Variability of pharmacokinetic parameters in patients receiving different dosages of daptomycin: is therapeutic drug monitoring necessary?","volume":"19","author":"Falcone","year":"2013","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib1060","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/cid\/cit582","article-title":"Considerations for higher doses of daptomycin in critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia","volume":"57","author":"Falcone","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib1065","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1093\/cid\/ciu230","article-title":"Different recommendations for daptomycin dosing over time in patients with severe infections","volume":"58","author":"Di Paolo","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib1070","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1093\/jac\/dkt294","article-title":"A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis","volume":"68","author":"Kullar","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib1075","first-page":"286","article-title":"At least 8mg\/kg\/d for the treatment of infective endocarditis","volume":"44","author":"Flateau","year":"2014","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib1080","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/jac\/dkp346","article-title":"Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies","volume":"64","author":"Steenbergen","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib1085","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1128\/AAC.00536-10","article-title":"Novel daptomycin combinations against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations","volume":"54","author":"Steed","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib1090","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1128\/AAC.01525-12","article-title":"\u03b2-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives","volume":"56","author":"Mehta","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib1095","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1128\/AAC.00502-12","article-title":"Altering the proclivity towards daptomycin resistance in methicillin-resistant Staphylococcus aureus using combinations with other antibiotics","volume":"56","author":"Berti","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib1100","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1128\/AAC.00797-12","article-title":"Addition of ceftaroline to daptomycin after emergence of daptomycin-nonsusceptible Staphylococcus aureus during therapy improves antibacterial activity","volume":"56","author":"Rose","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib1105","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/cid\/cir340","article-title":"Use of antistaphylococcal \u03b2-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding","volume":"53","author":"Dhand","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib1110","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/jac\/dks453","article-title":"Evaluation of the combination of daptomycin and nafcillin against vancomycin-intermediate Staphylococcus aureus","volume":"68","author":"Leonard","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib1115","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00109-013-1100-7","article-title":"Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus","volume":"92","author":"Sakoulas","year":"2014","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.ijantimicag.2015.05.008_bib1120","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1128\/AAC.02192-12","article-title":"Multicenter evaluation of the clinical outcomes of daptomycin with and without concomitant \u03b2-lactams in patients with Staphylococcus aureus bacteremia and mild to moderate renal impairment","volume":"57","author":"Moise","year":"2013","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915002113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915002113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T05:22:06Z","timestamp":1566883326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857915002113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":112,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0924857915002113"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.05.008","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights and clinical perspectives of daptomycin resistance in Staphylococcus aureus: A review of the available evidence","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}